4
Changes in Ownership
MBX Biosciences, Inc. Filed Acc 0001193125-26-216704
Chief Medical Officer sold 70,003 shares at an average $38.36 ($2,685,515)
- Chief Medical Officer acquired 70,003 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Azoulay Salomon · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +55,000 | $10.46 | $575,300 | 69,769 | D |
| 2026-05-08 | Sale : show line 2 in the form 10b5-1 | −55,000 | $38.38 | $2,110,900 | 14,769 | D |
| 2026-05-08 | Exercise or conversion : show line 3 in the form 10b5-1 | +15,003 | $16.00 | $240,048 | 29,772 | D |
| 2026-05-08 | Sale : show line 4 in the form 10b5-1 | −15,003 | $38.30 | $574,615 | 14,769 | D |
| Open-market sales · 70,003 sh · avg $38.36 · $2,685,515 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-08 | Exercise or conversion : show line 5 in the form 10b5-1 Stock option (right to buy) | +55,000 | 194,540 | D |
| 2026-05-08 | Exercise or conversion : show line 6 in the form 10b5-1 Stock option (right to buy) | +15,003 | 30,008 | D |
Loading xslF345X06/ownership.xml…